Significant Ownership of ACORN BIOVENTURES, L.P.

Signature - Title
Anders Hove - Manager of General Partner
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by ACORN BIOVENTURES, L.P..

Follow Filing Activity

Follow ACORN BIOVENTURES, L.P. and return when a new Schedule 13D/G filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Significant Ownership of ACORN BIOVENTURES, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
OKUR OnKure Therapeutics, Inc. Common stock, par value $0.0001 per share 22% $7,099,185 2,839,674 Anders Hove 15 May 2025
RPHM OnKure Therapeutics, Inc. Common Stock, $0.0001 Par Value 9.5% 3,924,037 Anders Hove 27 Mar 2026
BCAB BioAtla, Inc. Common Stock, $0.0001 par value per share 8.3% $2,127,449 4,835,111 Anders Hove 15 May 2025
PBYI PUMA BIOTECHNOLOGY, INC. Common Stock, $0.0001 par value per share 8% $11,859,557 +$1,988,442 3,940,052 +20% Anders Hove 31 Dec 2024
MURA Mural Oncology plc Common Stock, $0.01 par value per share 7.6% $3,369,527 +$547,205 1,286,079 +19% Anders Hove 31 Dec 2024
YMAB Y-mAbs Therapeutics, Inc. Common stock, par value $0.0001 per share 6.2% $13,338,337 -$1,431,000 2,796,297 -9.7% Anders Hove 19 Aug 2025
ATHA Athira Pharma, Inc. Common Stock, $0.0001 Par Value 6.2% $1,345,504 +$212,929 596,068 +19% Anders Hove 06 Jan 2026
JSPR Jasper Therapeutics, Inc. Common Stock, $0.001 Par Value 5.3% $2,660,821 -$537,000 1,486,492 -17% Anders Hove 23 Jan 2026
CADL Candel Therapeutics, Inc. Common stock, par value $0.0001 per share 5.2% $14,115,428 2,580,517 Anders Hove 25 Jun 2025

Schedules 13D/G Reported by ACORN BIOVENTURES, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored